200 related articles for article (PubMed ID: 3070641)
1. [Disorders of cellular immunity in systemic scleroderma].
Sierakowski SJ; Kucharz EJ
Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
[No Abstract] [Full Text] [Related]
2. [Studies of the role of cellular immunity and angiogenetic changes in the pathogenesis of circumscribed scleroderma].
Majewski S; Błaszczyk M; Chibowska M; Rosińska-Borkowska D; Kencka D; Rudnicka L; Marczak M; Makieła B; Skiendzielewska A; Jabłońska S
Przegl Dermatol; 1990; 77(4):249-51. PubMed ID: 2267352
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
Iashchenko OB
Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
[No Abstract] [Full Text] [Related]
4. [T- and B-systems of immunity in diseases of the connective tissue (review of the literature and the authors' data)].
Lozovoĭ VP; Shergin SM
Ter Arkh; 1978; 50(9):135-45. PubMed ID: 360466
[No Abstract] [Full Text] [Related]
5. [Masking of pan-T-cell markers in patients with autoimmune diseases].
Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
[No Abstract] [Full Text] [Related]
6. [Immune diagnosis of collagen diseases].
Sönnichsen N
Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):519-21. PubMed ID: 6975540
[No Abstract] [Full Text] [Related]
7. Scleroderma.
Gilliam AC
Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
[TBL] [Abstract][Full Text] [Related]
8. [Glomerulonephritis in systemic lupus erythematosus].
Belovezhdov N
Vutr Boles; 1984; 23(1):1-9. PubMed ID: 6203232
[No Abstract] [Full Text] [Related]
9. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune diseases - immunological bases].
Jäger L
Z Gesamte Inn Med; 1975 Nov; 30(21):239-40 contd. PubMed ID: 55001
[No Abstract] [Full Text] [Related]
11. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.
Lou YH; McElveen MF; Garza KM; Tung KS
J Immunol; 1996 May; 156(9):3535-40. PubMed ID: 8617983
[TBL] [Abstract][Full Text] [Related]
12. [Abnormalities of lymphocytes in autoimmune-prone mice].
Inaba M; Ikehara S
Tanpakushitsu Kakusan Koso; 1990 Feb; 35(2):158-67. PubMed ID: 2181534
[No Abstract] [Full Text] [Related]
13. Mechanisms in autoimmune diseases.
Shanahan F; McLaughlin H
Ir Med J; 1977 Oct; 70(16):472-9. PubMed ID: 144714
[No Abstract] [Full Text] [Related]
14. [Immunoregulatory deviations and autoimmune diseases].
Yano K; Ofuji T
Nihon Rinsho; 1983; 41(4):756-60. PubMed ID: 6224949
[No Abstract] [Full Text] [Related]
15. [Immunologic mechanisms in aplastic anemia. I. Introduction: Immunological system in aplastic anemia].
Rupniewska ZM; Dmoszyńska-Giannopoulous A
Przegl Lek; 1982; 39(9):607-11. PubMed ID: 6758055
[No Abstract] [Full Text] [Related]
16. [Experimental models of systemic scleroderma].
Serakovski S; Kukhazh E; Bernatska K
Revmatologiia (Mosk); 1989; (3):36-46. PubMed ID: 2692123
[No Abstract] [Full Text] [Related]
17. New prospects for autoimmune disease therapy: B cells on deathwatch.
St Clair EW; Tedder TF
Arthritis Rheum; 2006 Jan; 54(1):1-9. PubMed ID: 16385491
[No Abstract] [Full Text] [Related]
18. [Cell-mediated immunity in autoimmune diseases (author's transl)].
Fukase M
Rinsho Byori; 1975 Jan; 23(1):40-6. PubMed ID: 1079062
[No Abstract] [Full Text] [Related]
19. [B and T lymphocytes in the blood].
Hokland P; Heron I
Ugeskr Laeger; 1979 May; 141(20):1311-4. PubMed ID: 313115
[No Abstract] [Full Text] [Related]
20. [Immunological pathogenesis of collagenosis].
Lorente Toledano F; Blanco Quirós A; Muriel Ramos MM
An Esp Pediatr; 1981 Jul; 15(1):23-30. PubMed ID: 6976141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
